BiotechTube
Home/Vera Therapeutics/Lauren Frenz, MBA
LF

Lauren Frenz, MBA

Chief Business Officer

Vera Therapeutics

Therapeutic Areas

NephrologyAutoimmune DiseasesInfectious Diseases

Vera Therapeutics Pipeline

DrugIndicationPhase
AtaciceptIgA Nephropathy (IgAN)Phase 2b/3
MAU868BK Virus Viremia in Kidney Transplant PatientsPhase 2

Leadership Team at Vera Therapeutics

MF
Marshall Fordyce, MD
CEO and Founder
RM
Robert M. Brenner, MD
Chief Medical Officer
View full Vera Therapeutics profile